Nieuw medicijn lecanemab kan mogelijk alzheimer afremmen, maar er zijn wel nog zorgen
De ziekte van Alzheimer is dan toch behandelbaar. Dat blijkt toch uit studieresultaten van farmabedrijven Eisai en Biogen, die samen het nieuwe ... |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources.. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.